| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/14/2006 | US20060205691 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205661 Novel albumin-free factor VIII formulations |
| 09/14/2006 | US20060205648 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides |
| 09/14/2006 | US20060204986 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | US20060204584 Materials and methods relating to polyions and substance delivery |
| 09/14/2006 | US20060204582 Multiple phase cross-linked compositions and uses thereof |
| 09/14/2006 | US20060204579 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal |
| 09/14/2006 | US20060204577 Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers |
| 09/14/2006 | US20060204569 Functional starch powder |
| 09/14/2006 | US20060204565 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 09/14/2006 | US20060204559 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/14/2006 | US20060204551 Synergistic salivation agents |
| 09/14/2006 | US20060204550 Food and beverages containing L-carnitine derivatives |
| 09/14/2006 | US20060204549 Method of improving nutrient utilisation by a mammal and a composition for use therein |
| 09/14/2006 | US20060204543 Semirigid implant of glycolic acid-lactic acid copolymer with hydroxypropylmethyl cellulose as release modifier for cyclosporine; biodegradation; sustained release |
| 09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204511 Use of recombinant or synthetic gelatin as stabiliser in vaccines |
| 09/14/2006 | US20060204499 Tumour necrosis factor binding ligands |
| 09/14/2006 | US20060204490 Hemostatic compositions containing sterile thrombin |
| 09/14/2006 | US20060204472 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 09/14/2006 | US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 09/14/2006 | US20060204440 Radio-opaque polymeric biomaterials |
| 09/14/2006 | CA2745782A1 Pharmaceutical compositions and uses for peptide treatment |
| 09/14/2006 | CA2602007A1 Particle and preparation containing the particle |
| 09/14/2006 | CA2601279A1 Formulation for aviptadil |
| 09/14/2006 | CA2601011A1 Sugar-coated pill |
| 09/14/2006 | CA2600969A1 Soft gelatin capsules containing cyclodextrin in the capusle shell |
| 09/14/2006 | CA2600836A1 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
| 09/14/2006 | CA2600638A1 Composition comprising emodepside and praziquantel or epsiprantel |
| 09/14/2006 | CA2600434A1 Anti-ctla-4 antibody compositions |
| 09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
| 09/14/2006 | CA2600085A1 Microparticle and pharmaceutical preparation |
| 09/14/2006 | CA2599968A1 Topical gels compositions |
| 09/14/2006 | CA2599290A1 Ketoprofen sis adhesive for skin adhesive plaster |
| 09/14/2006 | CA2599251A1 Microemulsions of cannabinoid receptor binding compounds |
| 09/14/2006 | CA2598528A1 Production of bioactive glycoproteins from inactive starting material |
| 09/14/2006 | CA2598353A1 Non-fibrous transdermal therapeutic system and method for its production |
| 09/14/2006 | CA2575730A1 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/13/2006 | EP1700911A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 09/13/2006 | EP1700605A2 Lyophilized methionine-containing protein preparations stabilized over long time |
| 09/13/2006 | EP1700593A1 Water-in-Oil dispersion comprising dextran fatty acid ester |
| 09/13/2006 | EP1700591A1 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
| 09/13/2006 | EP1699917A2 Stem cell targeting using magnetic particles |
| 09/13/2006 | EP1699847A1 Medicinal compositions and method for the preparation thereof |
| 09/13/2006 | EP1699837A1 Stereocomplex hydrogels with tunable degradation times |
| 09/13/2006 | EP1699810A2 A beta immunogenic peptide carrier conjugates and methods of producing same |
| 09/13/2006 | EP1699529A1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
| 09/13/2006 | EP1699500A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
| 09/13/2006 | EP1699492A2 Targeted immunogens |
| 09/13/2006 | EP1699491A2 Branched polyethylene glycol for linking polymer residues to antibodies |
| 09/13/2006 | EP1699490A2 Medical lipolysis of fat accumulations |
| 09/13/2006 | EP1699487A2 Novel anti-dc-sign antibodies |
| 09/13/2006 | EP1699482A2 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 09/13/2006 | EP1699443A2 Pharmaceutical formulations of bisphosphonates |
| 09/13/2006 | EP1699439A2 Controlled-release pharmaceutical formulation |
| 09/13/2006 | EP1699432A2 Injectable phosphatidylcholine preparations |
| 09/13/2006 | EP1578325A4 Stable topical drug delivery compositions |
| 09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
| 09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/13/2006 | EP1331948B1 Pharmaceutical composition containing honey for the treatment of wounds |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1296645B1 Methods for treating inflammation-mediated conditions of the eye |
| 09/13/2006 | EP1286655B1 Topical composition containing at least one aryl oxime, and method for the preparation thereof |
| 09/13/2006 | EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 09/13/2006 | EP1267843B1 System for transporting active substances in a biological system |
| 09/13/2006 | EP1227801B1 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1200040B8 Two-component composition for cosmetic or pharmaceutical use |
| 09/13/2006 | EP1196146B1 Powder particles with smooth surface for use in inhalation therapy |
| 09/13/2006 | EP1183050B1 Method for producing an injectable medicament preparation |
| 09/13/2006 | EP1179344B1 Release-regulating preparations |
| 09/13/2006 | EP1165126B1 Process for preparing a human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | CN1833020A Pro104 antibody compositions and methods of use |
| 09/13/2006 | CN1832959A Polyethelene glycol link glp-1 compounds |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1832762A Conjugates of hydroxyalkyl starch and g-csf |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1832760A Bioadhesive gel based on hydroxyethylcellulose |
| 09/13/2006 | CN1832759A Preventative effects of morinda citrifolia on mammary breast cancer |
| 09/13/2006 | CN1832751A Periodontal disease therapeutic and/or preventive composition |
| 09/13/2006 | CN1832749A Viscosity-Stable bismuth-containing pharmaceutical compositions. |
| 09/13/2006 | CN1832730A Controlled release formulations |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1832683A Compositions for encapsulation and controlled release |
| 09/13/2006 | CN1830429A Medicinal chewing tablet used for antipyretic analgesic and its preparation method |
| 09/13/2006 | CN1830420A Injection type pH sepsitive chitin quarternary ammonium salt aquagel and its preparation method |
| 09/13/2006 | CN1274829C Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274366C Medicinal nano carbon microsphere and its application for preparing medicine to treat cancer |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274299C Doxy rhodol magnetic microglobule and its making method |
| 09/13/2006 | CN1274298C Disintegrants for deodoring effectively and their preparation |
| 09/13/2006 | CN1274297C Composition and drug form for curing oral nosomycosis |